Literature DB >> 26321746

Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer.

Mina Zamani1, Majid Sadeghizadeh2, Mehrdad Behmanesh1, Farhood Najafi3.   

Abstract

BACKGROUND: Hepatocellular carcinoma is the fifth most common cancer worldwide, with poor prognosis and resistance to chemotherapy. This gives novel cancer treatment methods an overwhelming significance. Epigenetic therapy of cancer is useful in reversing some of the cancer defects because of reversibility of the epigenetic alterations. Non-protein coding transcripts are the major part of our transcriptome. MEG3 is a tumor suppressor long non-coding RNA being expressed in many normal tissues. Methylation of MEG3 promoter region elicits the decrease in its expression in hepatocellular cancer cells. Bioactive nutrients including curcumin offer great potential in altering DNA methylation status which is catalyzed via DNMT1, DNMT3A and 3B.
PURPOSE: Herein, we aimed to study RNA-based epigenetic effects of dendrosomal curcumin (DNC) on hepatocellular cancer (HCC). STUDY
DESIGN: To this end miRNA-dependent regulation of MEG3 expression under treatment with DNC was studied by evaluating the modulatory involvement of miR-29a for DNMT3A and 3B and miR-185 for DNMT1.
METHODS: We evaluated DNC entrance to HCC cells with the use of fluorescent characteristics of curcumin. Next we performed the MTT assay to evaluate DNC and dendrosome effects on HCC cell viability. The coding and non-coding genes expression analyses were done using quantitative-PCR.
RESULTS: In result we found that the DNC dependent overexpression of miR-29a and miR-185 (P < 0.01) can down-regulate the expression of DNMT1, 3A and 3B (P < 0.05) and subsequently overexpresses MEG3 (P < 0.05).
CONCLUSION: DNC potentially can induce DNA hypomethylation and reexpression of silenced tumor suppressor genes in HCC. These data suggest that DNC could be an effective choice for epigenetic therapy of HCC.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  DNA methylation; Dendrosomal curcumin; Epigenetic therapy; Hepatocellular cancer; Long non-coding RNA; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26321746     DOI: 10.1016/j.phymed.2015.05.071

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  27 in total

Review 1.  Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.

Authors:  James A McCubrey; Kvin Lertpiriyapong; Linda S Steelman; Steve L Abrams; Li V Yang; Ramiro M Murata; Pedro L Rosalen; Aurora Scalisi; Luca M Neri; Lucio Cocco; Stefano Ratti; Alberto M Martelli; Piotr Laidler; Joanna Dulińska-Litewka; Dariusz Rakus; Agnieszka Gizak; Paolo Lombardi; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Giuseppe Montalto; Melchiorre Cervello
Journal:  Aging (Albany NY)       Date:  2017-06-12       Impact factor: 5.682

2.  Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.

Authors:  Mohammad Amin Mahjoub; Babak Bakhshinejad; Majid Sadeghizadeh; Sadegh Babashah
Journal:  Mol Biol Rep       Date:  2017-07-27       Impact factor: 2.316

Review 3.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

4.  Role of Curcumin in Regulating Long Noncoding RNA Expression in Cancer.

Authors:  Abolfazl Amini; Parand Khadivar; Ali Ahmadnia; Morteza Alipour; Muhammed Majeed; Tannaz Jamialahmadi; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Radiosensitizing effect of dendrosomal nanoformulation of curcumin on cancer cells.

Authors:  Tahereh Jalali Varnamkhasti; Meisam Jafarzadeh; Majid Sadeghizadeh; Mahdi Aghili
Journal:  Pharmacol Rep       Date:  2022-07-10       Impact factor: 3.919

6.  MicroRNA 4323 induces human bladder smooth muscle cell proliferation under cyclic hydrodynamic pressure by activation of erk1/2 signaling pathway.

Authors:  Yi Sun; Deyi Luo; Yuchun Zhu; Kunjie Wang
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

Review 7.  Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

Authors:  Eswar Shankar; Rajnee Kanwal; Mario Candamo; Sanjay Gupta
Journal:  Semin Cancer Biol       Date:  2016-04-23       Impact factor: 15.707

Review 8.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

Review 9.  Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

10.  Curcumin suppresses tumor growth of gemcitabine-resistant non-small cell lung cancer by regulating lncRNA-MEG3 and PTEN signaling.

Authors:  L Gao; T Shao; W Zheng; J Ding
Journal:  Clin Transl Oncol       Date:  2021-02-10       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.